Crossmark

Establishing 3D organoid models from patient-derived conditionally reprogrammed cells to bridge preclinical and clinical insights in pancreatic cancer

Crossref DOI link: https://doi.org/10.1186/s12943-025-02374-y

Published Online: 2025-06-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Jin Su

Park, Chan Hee

Kim, Eunyoung

Lee, Hee Seung

Lee, Jinyoung

Kim, Jeehoon

Kam, Eun Hee

Nam, Sanghee

Chung, Moon Jae

Park, Jeong Youp

Park, Seung Woo

Kim, Sangwoo

Leem, Galam

Bang, Seungmin
Funding

Funding for this research was provided by:

National Research Foundation Grants (RS-2022-NR069839)

National Research Foundation Grants (RS-2024-00352915)

Korea Health Industry Development Institute (RS-2025-02283199)
License Information

Text and Data Mining valid from 2025-06-03

Version of Record valid from 2025-06-03
More Information

Article History

Received: 14 January 2025

Accepted: 29 May 2025

First Online: 3 June 2025

Declarations

:

: This study was approved by the Institutional Review Board of Yonsei University Medical Center (number 4-2019-0614).

: Written informed consent was obtained from all the patients.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below